Lumiracoxiboptagelsen ændredes ikke hos patienter med moderat leverinsufficiens (Child- Pugh score 7- 8) sammenlignet med raske frivillige.
Compared to healthy subjects, exposure to lumiracoxib was not changed in patients with moderate hepatic impairment (Child-Pugh score 7-8).